NELL-1 enhanced bone mineralization
View Patent ↗This invention pertains to the discovery that the human NELL-1 gene induces or upregulates bone mineralization. The NELL-1 gene or gene product thus provides a convenient target for screening for modulators of bone mineralization. In addition, NELL-1 can be used to facilitate repair of bone fractures and/or to generally increase bone density.
1. A method for screening for an agent that modulates bone mineralization, said method comprising:
contacting an osteogenic cell expressing a NELL-1 gene with a test agent; and
detecting an expression level of said NELL-1 gene in the contacted cell, where a difference in the expression level of NELL-1 in an osteogenic cell that is not contacted indicates that said test agent is an agent that modulates bone mineralization, wherein the osteogenic cell is selected from the group consisting of an osteoblast, a mesenchymal cell, a fibroblast cell, a dura cell, a chondrocyte, a MC3T3 cell and a chondroblast.
2. The method of claim 1 , further comprising recording test agents that modulate expressions of the NELL-1 nucleic acid or NELL-1 protein in a database of test agents modulating NELL-1 activity or in a database of test agents modulating bone mineralization.
3. The method of claim 1 , wherein in said level of NELL-1 is detected by determining the expression level of a NELL-1 protein in said biological sample.
4. The method of claim 3 , wherein said detecting is via a method selected from the group consisting of capillary electrophoresis, a Western blot, mass spectroscopy, ELISA, immunochromatography, and immunohistochemistry.
5. The method of claim 1 , wherein said cell is cultured ex vivo.
6. The method of claim 1 , wherein said test agent is not an antibody.
7. The method of claim 1 , wherein said test agent is not a protein.
8. The method of claim 1 , wherein the osteogenic cell is a cell in a fetal calvarial cell culture.
9. A method for screening for an agent that modulates bone mineralization, said method comprising:
contacting an osteogenic cell expressing a NELL-1 gene with a test agent; and detecting an expression level of said NELL-1 gene in the contacted cell, where a difference in the expression level of NELL-1 in an osteogenic cell that is not contacted indicates that said test agent is an agent that modulates bone mineralization.